Literature DB >> 7946804

Effects of ACE inhibitors on coronary haemodynamics and angina pectoris.

M K Davies1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7946804      PMCID： PMC1025593          DOI： 10.1136/hrt.72.3_suppl.s52

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  38 in total

1.  Direct myocardial and coronary effects of enalaprilat in patients with dilated cardiomyopathy: assessment by a bilateral intracoronary infusion technique.

Authors:  J M Foult; O Tavolaro; I Antony; A Nitenberg
Journal:  Circulation       Date:  1988-02       Impact factor: 29.690

2.  ACE inhibition attenuates sympathetic coronary vasoconstriction in patients with coronary artery disease.

Authors:  R Perondi; A Saino; R A Tio; G Pomidossi; L Gregorini; P Alessio; A Morganti; A Zanchetti; G Mancia
Journal:  Circulation       Date:  1992-06       Impact factor: 29.690

3.  Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study.

Authors:  J L Rouleau; K Chatterjee; W Benge; W W Parmley; B Hiramatsu
Journal:  Circulation       Date:  1982-04       Impact factor: 29.690

4.  The variable effects of angiotensin converting enzyme inhibition on myocardial ischaemia in chronic stable angina.

Authors:  J Simon; R Gibbs; P A Crean; L Mockus; C Wright; G C Sutton; K M Fox
Journal:  Br Heart J       Date:  1989-08

5.  Acute effects of captopril on the coronary circulation of patients with hypertension and angina.

Authors:  P Daly; J L Rouleau; D Cousineau; J H Burgess
Journal:  Am J Med       Date:  1984-05-31       Impact factor: 4.965

6.  Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.

Authors:  J N Cohn; D G Archibald; S Ziesche; J A Franciosa; W E Harston; F E Tristani; W B Dunkman; W Jacobs; G S Francis; K H Flohr
Journal:  N Engl J Med       Date:  1986-06-12       Impact factor: 91.245

7.  Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions.

Authors:  S Yusuf; C J Pepine; C Garces; H Pouleur; D Salem; J Kostis; C Benedict; M Rousseau; M Bourassa; B Pitt
Journal:  Lancet       Date:  1992-11-14       Impact factor: 79.321

8.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Authors:  M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

9.  Modulation of coronary circulation and the cardiac matrix by the renin-angiotensin system.

Authors:  R Dietz; W Waas; W Haberbosch; T Süsselbeck; T Fischer; S Hauck; K J Osterziel
Journal:  Eur Heart J       Date:  1991-12       Impact factor: 29.983

10.  Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.

Authors:  J L Halperin; D P Faxon; M A Creager; T A Bass; C D Melidossian; H Gavras; T J Ryan
Journal:  Am J Cardiol       Date:  1982-11       Impact factor: 2.778
View more
  2 in total

Review 1.  Choosing the most appropriate treatment for stable angina. Safety considerations.

Authors:  S Asirvatham; C Sebastian; U Thadani
Journal:  Drug Saf       Date:  1998-07       Impact factor: 5.606

Review 2.  Physiology, genetics, and cardiovascular disease: focus on African Americans.

Authors:  Gary H Gibbons
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-04       Impact factor: 3.738
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.